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Abstract
Background: There is debate as to whether the association between C-reactive protein (CRP) and insulin
resistance is independent of body fatness, particularly central obesity. Therefore, the association among CRP, insulin
resistance and obesity was analyzed in Chinese patients with type 2 diabetes.
Methods: The study included 520 Chinese patients diagnosed with type 2 diabetes with CRP levels not exceeding
10 mg/L. The degree of insulin resistance was determined with the homeostasis model assessment of insulin
resistance (HOMA-IR). The CRP levels were categorized into quartiles from the lowest to the highest concentrations
(Q1-Q4).
Results: Body mass index (BMI) and waist circumference (WC) were both higher in Q4, Q3 and Q2 than those in
Q1. HOMA-IR was higher in Q2, Q3 and Q4 than that in Q1 (Q1 vs Q4, P < 0.001; Q1 vs Q3, P < 0.001; Q1 vs Q2,
P = 0.028). Log CRP was significantly correlated with log HOMA-IR (correlation coefficient: 0.230, P < 0.001) and BMI
(correlation coefficient: 0.305, P < 0.001) and WC (correlation coefficient: 0.240, P < 0.001) by Spearman correlation
analysis. Multiple linear regression analysis adjusting for age, gender and components of metabolic syndrome, log
CRP was also independently associated with log HOMA-IR (b coefficient, 0.168; P < 0.001) and WC (b coefficient,
0.131; P = 0.006).
Conclusion: These findings showed that insulin resistance was associated with CRP levels independent of
abdominal obesity in Chinese patients with type 2 diabetes, suggesting that abdominal obesity could only partly
explain the link between subclinical inflammation and insulin resistance.
1. Background
C-reactive protein (CRP), an easily measured marker of
systemic inflammation, is stimulated by other cytokines,
especially interleukin-6 (IL-6). Insulin resistance is fun-
damental to the pathogenesis of type 2 diabetes mellitus.
During the last few years, insulin resistance has been
shown to be strongly associated with CRP and body fat,
particularly visceral fat. However, the relationships
among obesity, CRP, and insulin resistance are complex.
There is debate as to whether the association between
CRP and insulin resistance is independent of body
fatness, particularly central obesity [1]. Several studies
showed that the association of CRP with insulin resis-
tance was independent of obesity [2-6]. Other studies,
however, demonstrated that the association between
CRP and insulin resistance was obesity dependent in
healthy population [7-10]. In these studies, the relation-
ship of CRP and insulin resistance was no longer evi-
dent after adjusting for various parameters related to
obesity. The aim of our study was to investigate whether
insulin resistance is associated with CRP independent of
abdominal obesity in the Chinese patients diagnosed
with type 2 diabetes.
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2.1. Subjects
Data were obtained from a cross-sectional study under-
taken to evaluate the prevalence of diabetic complica-
tions in Chinese patients with type 2 diabetes, aged over
30 years and living in downtown Shanghai [11-14].
Twenty residential areas administered by 20 residents’
committees were cluster sampled in the central area of
Shanghai between 1 February and 31 July 2004. Ques-
tionnaires to identify a history of diabetes were sent to
every household in these residential areas, and collected
by primary care clinicians and endocrinologists. Chinese
patients diagnosed with type 2 diabetes were identified
by the questionnaire using the diagnostic criteria recom-
mended by the American Diabetic Association in 1997
[15]. Enrolled patients were recruited to the present
study and included in the final analysis if their CRP
levels had been measured and were ≤10 mg/L (Figure
1). CRP levels >10 mg/L reflect acute inflammation [6],
and the present study focused only on patients with
low-grade systemic inflammation.
2.2. Measurement
Body height and weight were measured from the sub-
jects wearing light clothing without shoes (Horse Head
TS120, Shanghai, China). Body mass index (BMI) was
calculated from weight in kilogram divided by height in
meter square. Waist circumference was measured to the
nearest 0.1 cm, using a calibrated plastic tape measure
at the umbilical level in the late exhalation phase while
standing. The average of the last two measurements of
systolic and diastolic blood pressure was obtained from
the patients.
2.3. Laboratory examination
Using the Hitachi 7600-020 clinical analyzer (Hitachi
High-Technologies Corporation, Tokyo, Japan), serum
cholesterol was determined by the cholesterol oxidase-
paraaminophenazone method (CHO0560, Shanghai Jin-
gyuan Medical Appliances, Shanghai, China), serum trigly-
cerides by the glycerol phosphate oxidase-para-
aminophenazone method (TGP0560, Shanghai Jingyuan
Medical Appliances), high-density lipoproteincholesterol
(HDL-C) by the International Reagents Corporation
method (21200AMZ00404000, Daiichi Pure Chemicals,
Tokyo, Japan), low-density lipoprotein-cholesterol (LDL-
C) by the catalase method (20900AMZ00550000, Daiichi
Pure Chemicals), and serum creatinine by the sarcosine
oxidase-para-aminophenazone method (S708, Shanghai
Kehua Dongling Diagnostic Products, Shanghai, China).
Blood urea nitrogen levels were measured using the
UVGLDH Method (Cat.No.S507, Shanghai Kehua Don-
gling Diagnostic Products, Shanghai, China), and uric acid
was measured using the uricase-peroxidase coupling
method (Cat.No.S710, Shanghai Kehua Dongling Diagnos-
tic Products) according to the manufacturer’s instructions.
Glycosylated haemoglobin (HbA1c) was determined by
high-pressure liquid chromatography using an automated
HLC-723G7 analyser (Tosoh Corporation, Tokyo, Japan).
Serum insulin was evaluated by radioimmunoassay, after
fasting and then following a 2-h oral glucose tolerance
test (Beijing Atom HighTech, Beijing, China). Plasma
glucose levels were measured by the glucose oxidase
method (GOX0560, Shanghai Jingyuan Medical Appli-
ances) using a Hitachi 7600-020 clinical analyser. Insulin
resistance was estimated using the homeostasis model
assessment of insulin resistance (HOMA-IR) as follows:
fasting serum insulin (mIU/ml) × fasting plasma glucose
(mmol/l)/22.5. Serum CRP levels were measured by a
chemiluminescence assay using an automatic analyser
(Dade Behring, Marburg, Germany). This assay has a sen-
sitivity of 0.162 mg/L. Inter- and intraassay coefficients of
variation were <5% for the measurements. For the pur-
poses of this analysis, patients were divided into strata
according to quartiles of baseline CRP values(Q1~Q4).
2.4. Statistic analysis
Quantitative variables were described as mean ± S.D.
One-way ANOVA (multiple comparisons: LSD method)
was used for quantitative variables comparisons among
the four subgroups according to quartiles of CRP (P <
0.05 considered statistically significant). Chi-square test
was used for enumeration data comparisons among the
four subgroups according to quartiles of CRP (P value
was modified to 0.05/6 based on statistical error of the
first kind). The distribution of CRP and HOMA-IR
levels were highly skewed. Logarithmically transformed
values of CRP and HOMA-IR were used. Spearman cor-
relation analysis was performed to determine the rela-
tionship among CRP, HOMA-IR, BMI and waist
circumference. To explore the relationship between CRP
and HOMA-IR independent of obesity, the association
between CRP and HOMA-IR was tested by linear
regression analysis with log CRP as the dependent vari-
able. All statistical analyses were conducted with the
SPSS statistical package for Windows version 16.0
(SPSS, Chicago, IL).
 
1120 patients with type 2 diabetes identified by questionnaire 
81 did not join our chronic diabetic complications study 
1039 patients with type 2 diabetes enrolled in our chronic diabetic complications study 
First recruited 465 patients did not measure CRP; 
54 patients with CRP>10mg/L representing acute inflammtion 
520 patients analyzed in this study   
Figure 1 Screening and Enrollment of Study Subjects.
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A total of 520 patients including 194 male patients and
326 female patients were analyzed in this study. The
mean age of these 520 patients was 65.14 ± 12.11 years
and the duration of diabetes 7.11 ± 6.73 years.
3.1. Clinical characteristics among the four subgroups
stratified according to the quartiles of CRP (Q1-Q4)
Table 1 presented the difference of the clinical charac-
teristics among the four subgroups stratified according
to the quartiles of CRP (Q1-Q4). BMI and waist circum-
ference were higher in Q4, Q3 and Q2 than these in Q1.
BMI was higher in Q3 and Q4 than that in Q2. Systolic
blood pressure and diastolic blood pressure were signifi-
cantly higher in Q4, Q3 than these in Q1 and Q2.
Serum cholesterol, triglycerides and LDL-C were higher
in Q2 and Q3 than these in Q1. HDL-C was lower in
Q2 and Q3 than that in Q1. Gender was not signifi-
cantly correlated with CRP. HbA1c was also not signifi-
cantly correlated with CRP. Blood urea nitrogen and
serum creatinine were both not significantly correlated
with CRP levels. Serum uric acid in Q2 and Q3 was
higher than that in Q1 and Q4.
3.2. Relationships between CRP and HOMA-IR
Table 1 also showed that log HOMA-IR was higher in
Q2, Q3 and Q4 than that in Q1 (Q1 vs Q4, P < 0.001; Q1
vs Q3, P < 0.001; Q1 vs Q2, P = 0.028). Figure 2 displayed
the distribution of log HOMA-IR index after subjects
were classified according to the quartiles of CRP.
3.3. CRP in relation to HOMA-IR and abdominal obesity
To explore the relationship between CRP and insulin
resistance, spearman correlation between log CRP and
log HOMA-IR was analyzed. Log CRP was significantly
correlated with log HOMA-IR (correlation coefficient:
0.230, P < 0.001). To explore the relationship between
C R Pa n da b d o m i n a lo b e s i t y , spearman correlation
between log CRP and BMI, waist circumference was
analyzed. Log CRP was significantly correlated with BMI
(correlation coefficient: 0.305, P < 0.001) and waist cir-
cumference (correlation coefficient: 0.240, P < 0.001).
Table 1 Clinical characteristics among the four subgroups stratified according to the CRP quartiles
Parameters Q1 Q2 Q3 Q4
Log CRP (mg/L) -0.426 ± 0.209 0.062 ± 0.103 * 0.434 ± 0.116 * † 0.781 ± 0.112 * †‡
CRP (Media) 0.410 1.130 2.850 5.795
Age (years) 62.46 ± 13.46 64.08 ± 12.51 67.25 ± 11.17 * † 66.85 ± 10.56 *
Female/total 78/130 76/130 87/130 85/130
Duration (years) 7.58 ± 7.56 7.22 ± 6.99 6.65 ± 5.76 6.98 ± 6.48
BMI (kg/m2) 23.61 ± 3.14 24.47 ± 3.22 * 25.84 ± 3.22 * † 26.12 ± 3.92 * †
WC (cm) 82.20 ± 8.31 84.85 ± 9.28 * 88.45 ± 8.77 * † 86.92 ± 9.46 *
Systolic BP (mmHg) 130.93 ± 22.64 * 134.73 ± 23.86 140.39 ± 20.62 * † 142.74 ± 20.47 * †
Diastolic BP (mmHg) 77.16 ± 11.12 78.84 ± 10.56 81.84 ± 11.11* † 84.25 ± 10.18 * †
FBG (mg/dl) 144.90 ± 56.52 157.32 ± 63.18 153.00 ± 44.82 154.08 ± 51.48 ‡
PBG(mg/dl) 236.34 ± 100.98 269.10 ± 107.46 * 259.20 ± 93.60 278.10 ± 97.20 *
HbA1c (%) 6.91 ± 1.69 7.40 ± 1.87 * 7.29 ± 1.36 7.23 ± 1.44 ‡
BUN(mg/dl) 17.55 ± 5.45 16.43 ± 4.52 16.76 ± 4.35 17.27 ± 4.89
Cr (mg/dl) 0.89 ± 0.34 0.87 ± 0.22 0.88 ± 0.28 0.88 ± 0.27
UA (mg/dl) 5.01 ± 1.12 5.37 ± 1.37 * 5.54 ± 1.23 * 4.95 ± 1.21 †‡
TC (mg/dl) 193.69 ± 35.95 209.15 ± 46.78 * 211.08 ± 49.10 * 210.31 ± 47.94*
TG (mg/dl) 138.25 ± 103.25 190.75 ± 168.00 * 196.00 ± 121.63 * 168.00 ± 86.63
LDL-C (mg/dl) 113.66 ± 25.90 124.49 ± 35.95 * 124.49 ± 38.66* 119.46 ± 35.95
HDL-C (mg/dl) 49.48 ± 13.53 45.62 ± 10.44 * 45.62 ± 11.98 * 50.26 ± 14.69 †‡
Log HOMA-IR 0.457 ± 0.334 0.554 ± 0.355 * 0.636 ± 0.381 * 0.671 ± 0.343 * †
Data were presented as mean ± S.D. except gender and CRP. One-way analysis of variance or Pearson’s c2-test.
CRP: high-sensitivity C-reactive protein; WC: waist circumference; Systolic BP: systolic blood pressure; Diastolic BP: diastolic blood pressure; FBG: fasting blood
glucose; PBG: postprandial blood glucose; HbA1c: glycosylated haemoglobin; BUN: blood urea nitrogen; Cr: creatinine; UA: serum uric acid; TC: serum cholesterol;
TG: serum triglycerides; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; HOMA-IR, homeostasis model assessment of insulin
resistance;
* Significantly different from Q1 subgroups (p < 0.05).
† Significantly different from Q2 subgroups (p < 0.05).
‡ Significantly different from Q3 subgroups (p < 0.05).
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resistance independent of obesity, the association
between CRP and the parameters of insulin resistance
was tested by linear regression analysis with log CRP as
the dependent variable (Table 2). The following cate-
gories including components of metabolic syndrome
were taken as independent variables: gender, age, waist
circumference, systolic blood pressure, diastolic blood
pressure, serum triglycerides, HDL-C, HbA1c and log
HOMA-IR. CRP was independently associated with log
HOMA-IR (b coefficient, 0.168; P < 0.001) and waist
circumference (b coefficient, 0.131; P = 0.006). If waist
circumference was replaced by BMI among the above
independent variables in the linear regression analysis,
CRP was also independently associated with log
HOMA-IR (b coefficient, 0.147; P = 0.003) and BMI
(b coefficient, 0.181; P < 0.001).
4. Discussion
All previous studies confirmed that abdominal fat distri-
bution was significantly associated with insulin resis-
tance. Chavez AO showed that simple morphometric
measurements of adiposity/obesity, (i.e. abdominal cir-
cumference) could explain 59% of total insulin mediated
glucose uptake, and provided a feasible method to
screen and identify insulin resistant in baboons [16].
Miyazaki Y showed that visceral fat dominant accumula-
tion as opposed to subcutaneous fat accumulation was
associated with hepatic insulin resistance, independent
of the individual’s body type, in male patients with type
2 diabetes [17]. Recently a study showed that epicardial
adipose tissue (EAT), as part of visceral fat, was also sig-
nificantly increased in patients with metabolic syndrome
and cardiovascular disease [18]. Moreover, lifestyle inter-
vention involving diet combined with initial or delayed
initiation of physical activity resulted in clinically signifi-
cant weight loss and favorable changes in insulin resis-
tance among patients with severe obesity [19].
How do we evaluate the role of low-grade systemic
inflammation in the association between insulin resis-
tance and obesity? Previous studies that examined the
relationships among insulin resistance, CRP, and obesity
were inconsistent. Several studies demonstrated that
insulin resistance, as expressed by HOMA-IR, was sig-
nificantly correlated with CRP concentrations in nondia-
betic general populations. However, this correlation was
abolished after adjusting for the parameters of obesity
[7,8]. Similar observationsw e r ea l s om a d ei nap o p u l a -
tion that was at high risk for the development of type 2
diabetes mellitus [10]. The vigorous ongoing debate
regarding the association among chronic inflammation
condition, insulin resistance and obesity provided a con-
flicting hypothesis that chronic inflammatory state origi-
nates from obesity and drives the insulin resistant
condition.
However, some studies concluded that the relationship
between CRP concentrations and insulin resistance was
independent of obesity. In the Insulin Resistance Ather-
osclerosis Study, Festa et al showed that CRP was
strongly associated with insulin sensitivity, as assessed
by a frequently sampled intravenous glucose tolerance
test; and this association was independent of BMI [2].
  *  Q1-Q4: Quartiles of CRP   
(mg/L) 
Figure 2 The distribution of log HOMA-IR index after subjects
was classified according to the quartiles of CRP.
Table 2 Multiple linear regression analysis of the
relationship between CRP and HOMA-IR
adjusted for the following variables including waist circumference
b coefficient P value
Gender 0.056 0.207
Age 0.103 0.031
Systolic BP -0.014 0.823
Diastolic BP 0.187 0.001
Triglycerides 0.054 0.254
HDL-c 0.028 0.557
HbA1c -0.005 0.918
Log HOMA-IR 0.168 <0.001
WC 0.131 0.006
adjusted for the following variables including BMI
b coefficient P value
Gender 0.015 0.732
Age 0.111 0.018
Systolic BP 0.008 0.893
Diastolic BP 0.148 0.010
Triglycerides 0.050 0.280
HDL-c 0.019 0.678
HbA1c 0.013 0.768
Log HOMA-IR 0.147 0.003
BMI 0.181 <0.001
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fasting insulin with CRP concentration even after adjust-
ing for BMI [5]. Gupta AK et al revealed the prediabetes
group had significantly higher CRP and fibrinogen than
those in normoglycemic group from healthy disease free
obese adults in a weight loss study. This study suggested
that a higher degree of systemic inflammation was asso-
ciated with insulin resistance independent of obesity,
concurrent prediabetes with prehypertension [20]. Chou
HH et al concluded that insulin resistance was asso-
ciated with C-reactive protein independent of abdominal
obesity in nondiabetic Chinese population [6]. In this
study we demonstrated that obesity and insulin resis-
t a n c ew e r es t r o n g l ya s s o c i a t e dw i t hC R P .T h e s ed a t a
extended previous reports done predominantly in non-
diabetic subjects. To more precisely define the relation-
ship between insulin resistance and CRP concentration,
we further examined this relationship after adjusting for
some metabolic factors in addition to age and gender. A
positive association of HOMA-IR with CRP concentra-
tion was still evident after adjusting for waist circumfer-
ence, indicating that this relationship was independent
of abdominal obesity in the patients with type 2 dia-
betes. Our results were consistent with another Asian
nondiabetic population study that demonstrated that the
strength of the association between HOMA-IR and CRP
was reduced, but the association remained statistically
significant after adjusting for BMI [4,5]. Gallagher EJ
considered that insulin resistance might be the underly-
ing cause for the metabolic syndrome. Insulin resistance
could be present in both obese and lean individuals, and
was associated with inflammation. The mechanism that
insulin resistance correlated with inflammation indepen-
dent of central obesity was partly explained by this
review [21].
Recently Nayak S et al revealed that adiponectin was
not correlated with inflammatory marker [22]. And
among non-obese persons, adiponectin correlated nega-
tively with IL-6 and HOMA-IR [23]. So the debates on
the association among inflammation state, insulin resis-
tance and obesity may continue, and some further stu-
dies should be done.
Our study has several strengths. The subjects we
included were all of population-based Han-Chinese
patients diagnosed with type 2 diabetes. Besides, we used
a uniform protocol, including standardized clinical
assessments, anthropometric measurements, and bio-
chemical measurements in a centralized core laboratory.
However, some possible limitations of our study should
be mentioned. First, because of the study’s cross-sectional
nature, our results do not establish causality. Second,
subjects taking some antidiabetic and statin agents were
n o te x c l u d e df r o mo u rs t u d y ,w h i c hm i g h th a v ei n f l u -
enced the association of CRP levels and might have also
affected the association of CRP with insulin resistance in
the multivariable analysis.
In conclusion, our findings showed that insulin resis-
tance was associated with CRP levels independent of
abdominal obesity in Chinese patients with type 2 dia-
betes, suggesting that abdominal obesity could only
partly explain the link between subclinical inflammation
and insulin resistance.
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